HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Endocrine Dysregulation in Addiction
Endocrine Dysregulation in Addiction
Substance use significantly impacts the endocrine system, disrupting hormonal balances essential for body functions. For example, chronic alcohol consumption can impair the hypothalamic-pituitary-adrenal (HPA) axis, leading to cortisol imbalances that affect stress responses. Opioid use often reduces testosterone levels, causing fatigue and mood disturbances. Endocrine dysregulation contributes to both the physical and psychological challenges in addiction recovery. Hormonal assessments and targeted treatments, such as hormone replacement therapy, can help mitigate these effects. Combining endocrine care with addiction treatment supports holistic recovery and long-term health improvement.
Committee Members
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States GAB 2026 Speakers
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States